tiprankstipranks
aTyr Pharma appoints Eric Benevich to the company’s Board
PremiumThe FlyaTyr Pharma appoints Eric Benevich to the company’s Board
3M ago
aTyr Pharma announces third positive DSMB review for efzofitimod
Premium
The Fly
aTyr Pharma announces third positive DSMB review for efzofitimod
3M ago
aTyr Pharma to present preclinical research on ATYR0101 at symposia on Firbosis
Premium
The Fly
aTyr Pharma to present preclinical research on ATYR0101 at symposia on Firbosis
3M ago
aTyr Pharma initiated with an Overweight at Wells Fargo
PremiumThe FlyaTyr Pharma initiated with an Overweight at Wells Fargo
5M ago
CVS Health upgraded, Mobileye downgraded: Wall Street’s top analyst calls
Premium
The Fly
CVS Health upgraded, Mobileye downgraded: Wall Street’s top analyst calls
5M ago
aTyr Pharma announces publication of Phase 1b/2a clinical trial ofefzofitimod
Premium
The Fly
aTyr Pharma announces publication of Phase 1b/2a clinical trial ofefzofitimod
5M ago
aTyr Pharma appoints Jayant Aphale as VP, technical operations
PremiumThe FlyaTyr Pharma appoints Jayant Aphale as VP, technical operations
7M ago
aTyr Pharma announces research study with Stanford Medicine
Premium
The Fly
aTyr Pharma announces research study with Stanford Medicine
7M ago
aTyr Pharma potentially poised to break out in 2025, says RBC Capital
Premium
The Fly
aTyr Pharma potentially poised to break out in 2025, says RBC Capital
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100